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Abstract
The selection of patients with acute lung injury/acute respiratory
distress syndrome (ALI/ARDS) to receive noninvasive ventilation
(NIV) is challenging, partly because there are few reliable selection
criteria. The study by Rana and colleagues in the previous issue of
Critical Care identifies metabolic acidosis and a lower oxygenation
index as predictors of NIV failure, although it is unable to identify
threshold values. It also demonstrates that treating patients with
NIV for ALI/ARDS and shock is an exercise in futility. Future
studies need to focus on criteria that will enable selection of
patients for whom NIV will have a high likelihood of success.
Although noninvasive ventilation (NIV) has been used to treat
acute respiratory failure for well over a decade, our know-
ledge on how best to apply it continues to evolve. Relatively
little debate surrounds its use for acute respiratory failure due
to exacerbations of chronic obstructive pulmonary disease
[1], cardiogenic pulmonary edema [2] or in immunocompro-
mised hosts [3]. However, its appropriate use to treat
hypoxemic respiratory failure, particularly patients with acute
lung injury/acute respiratory distress syndrome (ALI/ARDS),
remains unclear. In the previous issue of Critical Care, Rana
and colleagues [4] examine this application of NIV and
identify risk factors for failure.
Rana and colleagues [4] evaluated the outcomes of an
observational cohort of patients with ALI treated with NIV as
the initial mode of therapy. Of a total of 358 patients started
on NIV at one hospital over a 6 month period, 79 were identi-
fied as having ALI as defined by bilateral chest infiltrates, a
PaO2/FiO2 <300 and no evidence of left heart failure. After
excluding do not recussitate/do not intubate patients and two
who declined to participate, 54 patients were left for analysis.
Two-thirds of this group (38 patients or 70.3%) failed NIV,
including all 19 patients with shock. When those patients
without shock were evaluated in a multivariate logistic
regression analysis, metabolic acidosis (odds ratio 1.27, 95%
confidence interval 1.03-0.07 per unit of base deficit) and
severe hypoxemia (odds ratio 1.03, 95% confidence interval
1.01-1.05 per unit decrease in PaO2/FiO2) remained
significant predictors of NIV failure. Although statistically
significant, these odds ratios demonstrate a very weak
association.
Identifying factors that reliably predict NIV failure is desirable
so that patients likely to fail can be excluded. Antonelli and
colleagues [5] found that a PaO2/FiO2 ratio of 146 or less
after one hour of NIV was an independent risk factor for
intubation (odds ratio 2.51). The Rana study found that the
mean PaO2/FiO2 in the NIV success group was 147 and 112
in the failure group, but the timing of the measurement
relative to the initiation of NIV was not specified. Also,
although patients who showed improved oxygenation with
NIV tended to have better outcomes, this did not reach
significance. The small numbers and lack of a clear
oxygenation threshold for NIV failure limits the clinical
applicability of these data. Acidosis has also been identified
as a predictor of NIV failure in earlier trials [6], and the finding
by Rana and colleagues that metabolic acidosis was
associated with NIV failure, reflected the greater severity of
illness in the patients who failed. Again, the lack of a
threshold value for acidosis limits the clinical applicability of
these findings. Nonetheless, the findings underline the
importance of obtaining baseline arterial blood gases when
assessing ALI/ARDS patients for receipt of NIV.
Considering that hypotensive shock has been considered a
contraindication to NIV in many of the controlled trials [7], it is
a bit shocking that 35% of the patients who were included in
the Rana cohort had septic shock. Although the authors are
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correct in stating that no prior evidence supported the
proscription, their finding that all 19 patients with septic
shock who were placed on NIV failed should lay the issue to
rest and solidify the place of septic shock on the list of
contraindications to NIV. Limitations of cohort analyses like
that of Rana and colleagues include the lack of prospective
criteria for initiation of NIV and intubation in the face of NIV
failure. Thus, findings might reflect the biases of clinicians
managing the patients. Patients with worse oxygenation
indexes or metabolic acidoses or septic shock are intubated
because the clinicians were responding to preconceived
biases and the predictors, in essence, are self-fulfilling
prophecies. Lacking a control group, this possibility cannot
be rejected. The lack of controls also precludes any
conclusions about efficacy. This is a particular limitation when
interpreting the finding that outcomes were much better in
patients succeeding on NIV than in those who failed
(mortality none versus 68%, respectively). This finding is
predictable, of course – those who avoid intubation tend to
do well. But lacking controls, it is impossible to know whether
the group as a whole (successes and failures) did better – or
worse – than it would have had intubation been the initial
therapy. This is of particular concern in view of the trial of
Esteban and colleagues [8], which showed an increased
intensive care unit mortality among NIV patients whose
intubation was delayed compared to controls. The concern is
that some patients treated with NIV as initial therapy might
have had their needed intubations delayed. In addition to
conferring better outcomes on the successes, NIV might
have worsened outcomes in patients whose intubations were
delayed. The study by Squadrone and colleagues [9] is
reassuring in this regard in that it demonstrated that patients
failing NIV fared no worse than patients intubated from the
start, but the patients had chronic obstructive pulmonary
disease, not ALI/ARDS.
An interesting and provocative speculation by the authors is
that the higher tidal volumes among patients who failed NIV
contributed to excessive lung stretch, worsening lung injury
and contributing to NIV failure. It seems at least equally likely
that the larger tidal volumes were markers of more severe
disease, reflecting higher rates of catabolism and larger
dead spaces, and this explains the worse outcomes.
However, we agree that it is an intriguing hypothesis that
requires more study.
What messages should we take away from the study by Rana
and colleagues regarding the selection of appropriate ALI
patients for a trial of NIV? Is there a severity of acute
respiratory failure beyond which NIV should not be used?
With our current NIV technology, it seems sensible to exclude
patients from consideration who have multi-organ dys-
function, or are poor candidates for NIV by virtue of inability to
cooperate or protect the airway, or because of excessive
secretions. Clearly, NIV should be avoided in patients with
shock, severe hypoxemia or acidosis. The more difficult issue
is whether there is a threshold of severity for hypoxemia and
acidosis beyond which NIV should be considered contra-
indicated. Unfortunately, the answer remains; we still don’t
know. The study by Rana and colleagues does not provide
sufficient precision to answer the question, even in the
context of prior studies. For now, we recommend selecting
ALI/ARDS patients for NIV according to general selection
guidelines [10]. These patients should be closely monitored
in an intensive care unit setting and, if there is no improve-
ment in oxygenation (PaO2/FiO2 into the range of 150), pH or
vital signs within the first 1 to 2 hours, intubated. The greatest
value of the Rana and colleagues study is to highlight the
need for larger prospective studies to better define criteria for
selecting ALI/ARDS patients for NIV.
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